2 completed, 2 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
Follow AZD1386: new trials by email Literature Review of AZD1386 trials Research Report on AZD1386
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD) AZD1386, Placebo to AZD1386 - Sensitivity in Esophagus | Phase 2 | Completed | AstraZeneca | 14 | 2009-11-01 | 2012-11-09 |
| Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain AZD1386, Placebo - Pain, Neuropathic Pain | Phase 2 | Terminated | AstraZeneca | 90 | 2009-09-01 | 2009-12-23 |
| Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee AZD1386, Placebo - Pain | Phase 2 | Terminated | AstraZeneca | 241 | 2009-03-01 | 2012-06-04 |
| Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386 AZD1386, Naproxen, Placebo - Pain | Phase 2 | Completed | AstraZeneca | 103 | 2008-04-01 | 2012-06-08 |
Pain (4) · Gastroesophageal Reflux (1) · Neuralgia (1) · Neuralgia, Postherpetic (1)
AstraZeneca (4)
Canada (2) · Denmark (2) · Bulgaria (1) · Finland (1) · France (1) · Hungary (1) · Japan (1) · Poland (1) · Slovakia (1) · Sweden (1) · United Kingdom (1) · United States (1)
Bror Jonzon (1) · Lynn Webster, MD (1) · Marie Sundin (1) · Ola Svensson, MD (1) · Peter Funch-Jensen,, MD, PhD (1) · Richard L Leff, MD (1) · Richard L Leff, md (1) · Rolf Karlsten, MD (1)
2008 (1)